Sai Life Sciences Limited (SAILIFE): research summary

Price history, fundamentals, business-quality scores, DCF intrinsic value, shareholding, quarterly results and risk metrics for Sai Life Sciences Limited, explained in plain English.

• ▪Sai Life Sciences Limited is tracked in the Pharma & Healthcare sector of the NSE universe covered here.
• ▪SAILIFE closed at ₹1,495.70 on 29 October 2026.
• ▪Over the past year the shares are up 63.2%, trading between ₹783.85 and ₹1,697.00.
• ▪Reported fundamentals show a net margin of 16.07%, debt to equity of 11.61.
• ▪Our transparent MaxGrade checklist scores it C (54/100) across momentum, growth, profitability and safety, using Pharma & Healthcare sector medians as the bar.
• ▪Annualised volatility over the past year is 33.78% with a maximum drawdown of -18.55% and a beta of 0.74 against NIFTY 50.
• ▪Recent coverage: Jefferies lists 6 factors that will shape CRDMO winners; Divi’s Labs, Sai Life, Laurus, Anthem among stocks to watch

Other Pharma & Healthcare companies: Abbott India, Acutaas Chemicals, Ajanta Pharmaceuticals, Alkem Laboratories, Anthem Biosciences, Apollo Hospitals Enterprise, Aster DM Quality Care, Aurobindo Pharma

Last traded values from 29 Oct 2026. Market opens at 9:15 IST.